详情页

当前位置：首页 > 详情页

Keynote-407 China Extension study: Pembrolizumab (pembro) plus chemotherapy in Chinese patients with metastatic squamous NSCLC

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China [2]Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing,China [3]Department of Pulmonary Medicine, Zhongshan Hospital Fudan University,Shanghai, China [4]Department of Oncology, Chongqing Cancer Hospital, Chongqing,China [5]Department of Respiratory Diseases, Xiangya Hospital Central South University,Changsha, China [6]Department of Respiratory Diseases, The First Affiliated Hospital ofZhejiang University, Hangzhou, China [7]Department of Thoracic Medicine, HunanCancer Hospital, Changsha, China [8]Department of Respiration, Anhui ProvincialHospital, Hefei, China [9]Department of Oncology, The First Affiliated Hospital of DalianMedical University, Dalian, China [10]Department of Oncology, Tang Du Hospital, Xi’an,China [11]Department of Oncology, The First Affiliated Hospital of Xi’An JiaotongUniversity, Xi’an, China [12]Department of Thoracic Medical Oncology, Beijing CancerHospital, Beijing, China [13]Department of Pulmonary Oncology, Affiliated Hospital ofAcademy of Military Medical Sciences, Beijing, China [14]Oncology, MSD China,Shanghai, China [15]Biostatistics, MSD China, Beijing, China [16]China CS, MSD China,Shanghai, China [17]Clinical Research-Oncology, Merck & Co., Inc., Kenilworth, USA [18]Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2019]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

影响因子： 65.4 最新[2024版] 46.8 最新五年平均 18.274 出版当年[2019版] 15.254 出版当年五年平均 14.196 出版前一年[2018版] 32.976 出版后一年[2020版]

第一作者：

第一作者机构： [1]Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China

推荐引用方式(GB/T 7714)：

APA：

MLA：